Table 2.
Best response status | N (%) |
---|---|
Clinical benefit (CB)a | 8 (23) |
Partial response (PR) | 1 (3) |
Stable disease ≥24 weeks (SD) | 7 (20) |
Progressive disease (PD) | 14 (40) |
Off study without confirmation of CB or PD | 13 (37) |
CB was defined as patients with complete response (CR), partial response (PR) or stable disease (SD) for ≥24 weeks